Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Torrent Group market capitalisation doubles to USD 20 billion in a year

Ruchika Sharma9 Jun 2024 6:30 PM IST

The Torrent Group, a diversified conglomerate, surpassed $20 billion (Rs 1.68 lakh crore) in market capitalization on Friday. This represents nearly a...

Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag International

JnJ Orthopaedics Company DePuy Synthes gets 510(k) FDA clearance of VELYS Robotic-Assisted Solution for use in Unicompartmental Knee Arthroplasty Procedures

Ruchika Sharma9 Jun 2024 4:00 PM IST

Palm Beach Gardens: Johnson & Johnson MedTech has announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, has...

GSK Blujepa bags USFDA nod for treatment of uUTIs in female adults, paediatric patients 12 years of age and older

USFDA approves expanded age indication for GSK RSV vaccine Arexvy for adults aged 50-59 at increased risk

Ruchika Sharma9 Jun 2024 10:00 AM IST

London: GSK plc has announced that the US Food and Drug Administration (FDA) has approved Arexvy (Respiratory Syncytial Virus (RSV) Vaccine,...

Abbott India Hit With Rs 2.40 Cr GST Penalty Over Alleged ITC Disallowance, Plans Appeal

Aveir DR: Abbott gets CE mark for Dual chamber leadless pacemaker system

Ruchika Sharma9 Jun 2024 10:00 AM IST

Abbott Park, Ill.: Abbott has announced the Company has received CE Mark in Europe for the AVEIR dual chamber (DR) leadless pacemaker system, a dual...

Fake drugs racket busted in Delhi, 4 held

Ruchika Sharma8 Jun 2024 1:30 PM IST

New Delhi: Four individuals, including a Syrian citizen, have been apprehended for purportedly producing and distributing fake cancer or diabetes...

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

Dr Reddy's Labs gets 4 USFDA observations for Srikakulam facility

Ruchika Sharma8 Jun 2024 12:30 PM IST

Hyderabad: Through a recent BSE filing, Dr Reddy's Labs has informed that the United States Food & Drug Administration (USFDA) has completed...

Gland Pharma names Srinivas Sadu as Executive Chairman, CEO

Ruchika Sharma8 Jun 2024 11:30 AM IST

Hyderabad: Gland Pharma Limited, a generic injectable-focused pharmaceutical company, has announced that Srinivas Sadu, the incumbent Managing...

California judge allows Glucerna lawsuit against Abbott Labs to proceed

Ruchika Sharma8 Jun 2024 10:30 AM IST

A California federal judge ruled on Wednesday that litigation against Abbott Laboratories alleging the marketing of Glucerna shakes and nutritional...

NPPA Finally Allows GSK to Discontinue Grisovin FP

GSK acquires Elsie Biotechnologies for up to USD 50 million

Ruchika Sharma7 Jun 2024 4:22 PM IST

London: GSK plc has announced that it has acquired Elsie Biotechnologies, a San Diego-based private biotechnology company working on unlocking the...

Eli Lilly in Talks to Acquire Ventyx Biosciences in USD 1 Billion-Plus Deal

No major concerns raised by USFDA staff on Eli Lilly Alzheimer's drug Donanemab

Ruchika Sharma7 Jun 2024 2:00 PM IST

London: FDA examination of trial data for Eli Lilly's investigational Alzheimer's drug Donanemab uncovered no red flags but did highlight safety...

Nestle India under SEBI net, gets warning letter

Nestle Health arm to buy global rights to VOWST

Ruchika Sharma7 Jun 2024 12:30 PM IST

Seres Therapeutics, Inc., has announced that it has agreed to a non-binding memorandum of understanding with Nestle Health Science in which Nestle...

Johnson & Johnson-backed Rapport Therapeutics secures USD 154 million in US IPO

Ruchika Sharma7 Jun 2024 11:30 AM IST

London: Rapport Therapeutics,, backed by the venture capital arm of Johnson & Johnson has said that the Company has secured $154...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok